Nelson Advisors: European HealthTech M&A Hotspots for 2027. A caveat before we start. Forecasting M&A a year out is partly about spotting where the money already is and partly about guessing where the next wave of consolidation breaks. We have tried to anchor each pick in transactions that have actually closed or been announced in 2025/2026 and to be candid where the thesis depends on things that haven't yet happened. Figures quoted from advisers and data providers are their

The European healthcare technology, medical devices (Medtech) and artificial intelligence (Health AI) ecosystems have transitioned from post-pandemic venture fragmentation into a disciplined era of industrial maturity. Following a severe liquidity drought that curtailed capital deployment and delayed public listings between late 2021 and 2024, the public offering window is reopening under fundamentally altered underwriting standards. Institutional public equity allocators no

The European behavioural health technology ecosystem is undergoing a structural paradigm shift. The initial wave of digital mental health, dominated by general consumer wellness, unguided meditation apps, and simple direct to consumer therapy marketplaces, has given way to a clinical grade ecosystem. As public healthcare systems across Europe face chronic clinician shortages and mounting therapy waitlists, governments, enterprise employers and institutional insurers are deman